Company intelligence / Profile preview

Biopsee

Ownership: Private
Development stage: Commercial

Overview

Biopsee offers an endoscopic imaging system that combines advanced biomedical cell analysis with optical systems and algorithmic processing to provide in vivo pathological-level images. This enables improved clinical diagnosis, treatment planning, and follow-up by delivering real-time high-resolution images at the cellular level. No specific clinical trial results are reported.

Therapeutic areas: OncologyOther
Modalities: DeviceImaging system
Industry: Medical Imaging

Beyond the preview

Go deeper on Biopsee.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biopsee.

Explore the full profile